The possible association of proton pump inhibitor use with acute cholangitis in patients with choledocholithiasis: a multi-center study

References

• Everhart JE, Khare M, Hill M, et al. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632–639.
   PubMed Web of Science ®Google Scholar
• Diehl AK, Sugarek NJ, Todd KH. Clinical evaluation for gallstone disease: usefulness of symptoms and signs in diagnosis. Am J Med. 1990;89(1):29–33.
   PubMed Web of Science ®Google Scholar
• Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg. 1993;165(4):399–404.
   PubMed Web of Science ®Google Scholar
• Collins C, Maguire D, Ireland A, et al. A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited. Ann Surg. 2004;239(1):28–33.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Takada T, Kawarada Y, et al. Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):15–26.
   PubMedGoogle Scholar
• Forsmark CE, Baillie J. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007;132(5):2022–2044.
   PubMed Web of Science ®Google Scholar
• Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci. 1992;37(5):689–696.
   PubMed Web of Science ®Google Scholar
• Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2–3.
   PubMed Web of Science ®Google Scholar
• Hojo M, Asahara T, Nagahara A, et al. Gut microbiota composition before and after use of proton pump inhibitors. Dig Dis Sci. 2018;63(11):2940–2949.
   PubMed Web of Science ®Google Scholar
• Vesper BJ, Jawdi A, Altman KW, et al. The effect of proton pump inhibitors on the human microbiota. Curr Drug Metab. 2009;10(1):84–89.
   PubMed Web of Science ®Google Scholar
• Jackson MA, Goodrich JK, Maxan M-E, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65(5):749–756.
   PubMed Web of Science ®Google Scholar
• Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740–748.
   PubMed Web of Science ®Google Scholar
• Takagi T, Naito Y, Inoue R, et al. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. J Clin Biochem Nutr. 2018;62(1):100–105.
   PubMed Web of Science ®Google Scholar
• Kamada N, Chen GY, Inohara N, et al. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685–690.
   PubMed Web of Science ®Google Scholar
• Canani RB, Terrin G. Gastric acidity inhibitors and the risk of intestinal infections. Curr Opin Gastroenterol. 2010;26(1):31–35.
   PubMed Web of Science ®Google Scholar
• Schneider J, Weidner W, Hapfelmeier A, et al. The use of proton pump inhibitors and the spectrum and number of biliary pathogens in patients with acute cholangitis. Aliment Pharmacol Ther. 2014;39(10):1194–1203.
   PubMed Web of Science ®Google Scholar
• Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2019;51(5):472–491.
   PubMed Web of Science ®Google Scholar
• Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther. 2005;22(Suppl 1):55–63.
   PubMed Web of Science ®Google Scholar
• Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American gastroenterological association. Gastroenterology. 2017;152(4):706–715.
   PubMed Web of Science ®Google Scholar
• Reimer C, Søndergaard B, Hilsted L, et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137(1):80–87.e1.
   PubMed Web of Science ®Google Scholar
• Niklasson A, Lindström L, Simrén M, et al. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol. 2010;105(7):1531–1537.
   PubMed Web of Science ®Google Scholar
• Haastrup PF, Jarbøl DE, Thompson W, et al. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterol. 2021;8(1):e000563.
   PubMed Web of Science ®Google Scholar
• Kadah A, Khoury T, Mahamid M, et al. Predicting common bile duct stones by non-invasive parameters. Hepatobiliary Pancreat Dis Int. 2020;19(3):266–270.
   PubMed Web of Science ®Google Scholar
• Shin G-Y, Park JM, Hong J, et al. Use of proton pump inhibitors vs histamine 2 receptor antagonists for the risk of gastric cancer: population-based cohort study. Am J Gastroenterol. 2021;116(6):1211–1219.
   PubMed Web of Science ®Google Scholar
• Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153(1):35–48.
   PubMed Web of Science ®Google Scholar
• Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117(5):e817–e820.
   PubMed Web of Science ®Google Scholar
• Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 2018;24(2):182–196.
   PubMed Web of Science ®Google Scholar
• Sbeit W, et al. Proton pump inhibitor use may increase the risk of diverticulitis but not it’s severity among patients with colonic diverticulosis: a multicenter study. J Clin Med. 2020;(9):2966.
   PubMed Web of Science ®Google Scholar
• Min YW, Kang D, Shin J-Y, et al. Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study. Aliment Pharmacol Ther. 2019;50(7):760–768.
   PubMed Web of Science ®Google Scholar
• Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96(2):94–102.
   PubMed Web of Science ®Google Scholar
• Ho BL, Hu HY, Chang SS. Association between use of proton pump inhibitors and occurrence of Colon diverticulitis. J Chin Med Assoc. 2016;79(1):5–10.
   PubMed Web of Science ®Google Scholar
• Agarwal N, Sharma BC, Sarin SK. Endoscopic management of acute cholangitis in elderly patients. World J Gastroenterol. 2006;12(40):6551–6555.
   PubMed Web of Science ®Google Scholar
• Picardi A, Vespasiani-Gentilucci U. Proton pump inhibitor prescription abuse and sepsis in cirrhosis. World J Gastrointest Pharmacol Ther. 2016;7(1):1–4.
   PubMedGoogle Scholar